The U.S. Food and Drug Administration has approved the Zycubo (copper histidinate) injection as the first treatment for ...
A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...
Saudi Arabia leads the way as the first country to grant conditional approval for Anktiva, a groundbreaking treatment for ...
Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva (nogapendekin alfa inbakicept) in combination with immunotherapy for adult patients ...
“It gives me the ick when influencers share weight loss advice” says Yorkshire pharmacist Nadia Malik.
With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...
The Food and Drug Administration (FDA) has approved Zycubo® (copper histidinate) for the treatment of Menkes disease in pediatric patients.
MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Subcutaneous administration takes less time and is tied to fewer administration-related reactions than intravenous.
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...
Eisai and Biogen have won FDA approval for a subcutaneous injection version of Leqembi that could help accelerate uptake of the Alzheimer's disease therapy. The green light for Leqembi Iqlik ...